Skip to main content

FOIA and the Grant Proposals

Over the weekend, a reader wrote into DrugMonkey and PhysioProf's blog about having received a Freedom of Information Act request from an anonymous physician at another research university for a recently-funded grant. The reader writes that the grant includes unpublished data and the lab's research plan and that after trying to work out a confidentiality agreement with the petitioner, the reader's university hired a lawyer. "Imagine being forced to share your unpublished data and research plan with an anonymous colleague when you wrote the grant with the understanding it would stay confidential!" the reader writes. Commenters to the blog wonder if any aspects of the grant would be able to be redacted to protect trade secrets or the unpublished data.

Toward the bottom of the comments, the original reader updates the post to say that the request was rescinded, though the discussion carries on.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.